Probiotic Lactobacillus plantarum GUANKE effectively alleviates allergic rhinitis symptoms by modulating functions of various cytokines and chemokines

Currently, the prevalence of allergic rhinitis (AR) remains high and there is a great need to develop better and safer ways to alleviate AR symptoms. The GUANKE probiotic was reported as an immunomodulator through maintaining Th1/Th2 balance. This study aimed to determine the efficacy of GUANKE in A...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in nutrition (Lausanne) Vol. 10; p. 1291100
Main Authors Han, Haijun, Chen, Guoliang, Zhang, Bin, Zhang, Xuewen, He, Jingmin, Du, Wenjuan, Li, Ming D.
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 15.01.2024
Subjects
Online AccessGet full text
ISSN2296-861X
2296-861X
DOI10.3389/fnut.2023.1291100

Cover

Loading…
Abstract Currently, the prevalence of allergic rhinitis (AR) remains high and there is a great need to develop better and safer ways to alleviate AR symptoms. The GUANKE probiotic was reported as an immunomodulator through maintaining Th1/Th2 balance. This study aimed to determine the efficacy of GUANKE in AR subjects. Adults aged from 18 to 60 years old and previously suffered from AR were recruited and received GUANKE probiotics treatment for 4 weeks. The questionnaires of Total nasal symptom scores (TNSS), total non-nasal symptom score (TNNSS), and rhinitis control assessment test (RCAT) were used to assess the effectiveness before and after treatment. The serum allergen-specific IgE and cytokines were also determined at baseline and after 4 weeks of probiotics administration. The results showed that TNSS and TNNSS were significantly reduced and the RCAT score was significantly increased compared to baseline. The sub-symptom score of rhinorrhea, itching, sneezing, and tearing in each questionnaire also showed significant changes, and the serum IgE level was markedly decreased. We further measured inflammatory-related proteins in serum and found that a total of 20 proteins (6 upregulated and 14 downregulated) were significantly changed compared to baseline, including IL-4, IL-7, IL-20, IL-33, CXCL1, CXCL5, CXCL6, CXCL11, CCL4, CCL23, TGF-alpha, LAP-TGF-beta-1, MMP-1, MMP-10, AXIN1, NT-3, OSM, SCF, CD6, and NRTN. Enrichment analysis showed that these significantly altered proteins were mainly enriched in cytokine and chemokine-related signaling pathways. Taken together, this study demonstrated the GUANKE can serve as an effective immunobiotic for the treatment of AR, which is realized through maintaining the Th1/Th2 balance by modulating the functions of various cytokines and chemokines.
AbstractList BackgroundCurrently, the prevalence of allergic rhinitis (AR) remains high and there is a great need to develop better and safer ways to alleviate AR symptoms. The Lactobacillus plantarum GUANKE probiotic was reported as an immunomodulator through maintaining Th1/Th2 balance. This study aimed to determine the efficacy of GUANKE in AR subjects.MethodsAdults aged from 18 to 60 years old and previously suffered from AR were recruited and received GUANKE probiotics treatment for 4 weeks. The questionnaires of Total nasal symptom scores (TNSS), total non-nasal symptom score (TNNSS), and rhinitis control assessment test (RCAT) were used to assess the effectiveness before and after treatment. The serum allergen-specific IgE and cytokines were also determined at baseline and after 4 weeks of probiotics administration.ResultsThe results showed that TNSS and TNNSS were significantly reduced and the RCAT score was significantly increased compared to baseline. The sub-symptom score of rhinorrhea, itching, sneezing, and tearing in each questionnaire also showed significant changes, and the serum IgE level was markedly decreased. We further measured inflammatory-related proteins in serum and found that a total of 20 proteins (6 upregulated and 14 downregulated) were significantly changed compared to baseline, including IL-4, IL-7, IL-20, IL-33, CXCL1, CXCL5, CXCL6, CXCL11, CCL4, CCL23, TGF-alpha, LAP-TGF-beta-1, MMP-1, MMP-10, AXIN1, NT-3, OSM, SCF, CD6, and NRTN. Enrichment analysis showed that these significantly altered proteins were mainly enriched in cytokine and chemokine-related signaling pathways.ConclusionTaken together, this study demonstrated the Lactobacillus plantarum GUANKE can serve as an effective immunobiotic for the treatment of AR, which is realized through maintaining the Th1/Th2 balance by modulating the functions of various cytokines and chemokines.
Currently, the prevalence of allergic rhinitis (AR) remains high and there is a great need to develop better and safer ways to alleviate AR symptoms. The Lactobacillus plantarum GUANKE probiotic was reported as an immunomodulator through maintaining Th1/Th2 balance. This study aimed to determine the efficacy of GUANKE in AR subjects.BackgroundCurrently, the prevalence of allergic rhinitis (AR) remains high and there is a great need to develop better and safer ways to alleviate AR symptoms. The Lactobacillus plantarum GUANKE probiotic was reported as an immunomodulator through maintaining Th1/Th2 balance. This study aimed to determine the efficacy of GUANKE in AR subjects.Adults aged from 18 to 60 years old and previously suffered from AR were recruited and received GUANKE probiotics treatment for 4 weeks. The questionnaires of Total nasal symptom scores (TNSS), total non-nasal symptom score (TNNSS), and rhinitis control assessment test (RCAT) were used to assess the effectiveness before and after treatment. The serum allergen-specific IgE and cytokines were also determined at baseline and after 4 weeks of probiotics administration.MethodsAdults aged from 18 to 60 years old and previously suffered from AR were recruited and received GUANKE probiotics treatment for 4 weeks. The questionnaires of Total nasal symptom scores (TNSS), total non-nasal symptom score (TNNSS), and rhinitis control assessment test (RCAT) were used to assess the effectiveness before and after treatment. The serum allergen-specific IgE and cytokines were also determined at baseline and after 4 weeks of probiotics administration.The results showed that TNSS and TNNSS were significantly reduced and the RCAT score was significantly increased compared to baseline. The sub-symptom score of rhinorrhea, itching, sneezing, and tearing in each questionnaire also showed significant changes, and the serum IgE level was markedly decreased. We further measured inflammatory-related proteins in serum and found that a total of 20 proteins (6 upregulated and 14 downregulated) were significantly changed compared to baseline, including IL-4, IL-7, IL-20, IL-33, CXCL1, CXCL5, CXCL6, CXCL11, CCL4, CCL23, TGF-alpha, LAP-TGF-beta-1, MMP-1, MMP-10, AXIN1, NT-3, OSM, SCF, CD6, and NRTN. Enrichment analysis showed that these significantly altered proteins were mainly enriched in cytokine and chemokine-related signaling pathways.ResultsThe results showed that TNSS and TNNSS were significantly reduced and the RCAT score was significantly increased compared to baseline. The sub-symptom score of rhinorrhea, itching, sneezing, and tearing in each questionnaire also showed significant changes, and the serum IgE level was markedly decreased. We further measured inflammatory-related proteins in serum and found that a total of 20 proteins (6 upregulated and 14 downregulated) were significantly changed compared to baseline, including IL-4, IL-7, IL-20, IL-33, CXCL1, CXCL5, CXCL6, CXCL11, CCL4, CCL23, TGF-alpha, LAP-TGF-beta-1, MMP-1, MMP-10, AXIN1, NT-3, OSM, SCF, CD6, and NRTN. Enrichment analysis showed that these significantly altered proteins were mainly enriched in cytokine and chemokine-related signaling pathways.Taken together, this study demonstrated the Lactobacillus plantarum GUANKE can serve as an effective immunobiotic for the treatment of AR, which is realized through maintaining the Th1/Th2 balance by modulating the functions of various cytokines and chemokines.ConclusionTaken together, this study demonstrated the Lactobacillus plantarum GUANKE can serve as an effective immunobiotic for the treatment of AR, which is realized through maintaining the Th1/Th2 balance by modulating the functions of various cytokines and chemokines.
Currently, the prevalence of allergic rhinitis (AR) remains high and there is a great need to develop better and safer ways to alleviate AR symptoms. The GUANKE probiotic was reported as an immunomodulator through maintaining Th1/Th2 balance. This study aimed to determine the efficacy of GUANKE in AR subjects. Adults aged from 18 to 60 years old and previously suffered from AR were recruited and received GUANKE probiotics treatment for 4 weeks. The questionnaires of Total nasal symptom scores (TNSS), total non-nasal symptom score (TNNSS), and rhinitis control assessment test (RCAT) were used to assess the effectiveness before and after treatment. The serum allergen-specific IgE and cytokines were also determined at baseline and after 4 weeks of probiotics administration. The results showed that TNSS and TNNSS were significantly reduced and the RCAT score was significantly increased compared to baseline. The sub-symptom score of rhinorrhea, itching, sneezing, and tearing in each questionnaire also showed significant changes, and the serum IgE level was markedly decreased. We further measured inflammatory-related proteins in serum and found that a total of 20 proteins (6 upregulated and 14 downregulated) were significantly changed compared to baseline, including IL-4, IL-7, IL-20, IL-33, CXCL1, CXCL5, CXCL6, CXCL11, CCL4, CCL23, TGF-alpha, LAP-TGF-beta-1, MMP-1, MMP-10, AXIN1, NT-3, OSM, SCF, CD6, and NRTN. Enrichment analysis showed that these significantly altered proteins were mainly enriched in cytokine and chemokine-related signaling pathways. Taken together, this study demonstrated the GUANKE can serve as an effective immunobiotic for the treatment of AR, which is realized through maintaining the Th1/Th2 balance by modulating the functions of various cytokines and chemokines.
Author Han, Haijun
Du, Wenjuan
Li, Ming D.
He, Jingmin
Chen, Guoliang
Zhang, Xuewen
Zhang, Bin
AuthorAffiliation 1 Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University , Hangzhou , China
4 College of Biological Sciences, Shanxi Agricultural University , Taigu, Shanxi , China
3 Department of Animal Science, Shanxi Agricultural University , Taigu, Shanxi , China
2 State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine , Hangzhou , China
AuthorAffiliation_xml – name: 3 Department of Animal Science, Shanxi Agricultural University , Taigu, Shanxi , China
– name: 4 College of Biological Sciences, Shanxi Agricultural University , Taigu, Shanxi , China
– name: 1 Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University , Hangzhou , China
– name: 2 State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine , Hangzhou , China
Author_xml – sequence: 1
  givenname: Haijun
  surname: Han
  fullname: Han, Haijun
– sequence: 2
  givenname: Guoliang
  surname: Chen
  fullname: Chen, Guoliang
– sequence: 3
  givenname: Bin
  surname: Zhang
  fullname: Zhang, Bin
– sequence: 4
  givenname: Xuewen
  surname: Zhang
  fullname: Zhang, Xuewen
– sequence: 5
  givenname: Jingmin
  surname: He
  fullname: He, Jingmin
– sequence: 6
  givenname: Wenjuan
  surname: Du
  fullname: Du, Wenjuan
– sequence: 7
  givenname: Ming D.
  surname: Li
  fullname: Li, Ming D.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38288067$$D View this record in MEDLINE/PubMed
BookMark eNp1ks1uEzEUhUeoiJbSB2CDvGST4J-JZ2aFqqotFRGwoBI7yz_XqYvHDrYnUl6E58VpUtQi4Y2v7Xu-I_nc181RiAGa5i3Bc8b64YMNU5lTTNmc0IEQjF80J5QOfNZz8uPoSX3cnOV8jzEmjC5a0r5qjllP-x7z7qT5_S1F5WJxGi2lLlFJ7byfMlp7GYpM04iub8-_fL5EYC3o4jbgt0h6DxsnC-SHMq2qPN254IrLKG_HdYljRmqLxmgmL4sLK2SnUOUxZBQt2sjkYnXR2xJ_urDjBIP0HYz745vmpZU-w9lhP21ury6_X3yaLb9e31ycL2e65bzMQCtteataYw23gE0LAyOUMisJMXQwxKqFZIyp3hjNu45gQhe0BdUDwRKz0-ZmzzVR3ot1cqNMWxGlEw8XMa2ETPVzPAhmCXSKMo7V0NpattLYRV2aGtl2pLI-7lnrSY1gNISSpH8Gff4S3J1YxY0guK9hYV4J7w-EFH9NkIsYXdbgaxRQf0vQgWLS95wPtfXdU7O_Lo_J1oZu36BTzDmBFdoVuQugejtfTcVujMRujMRujMRhjKqS_KN8hP9f8wdwH9Ex
CitedBy_id crossref_primary_10_1038_s41598_024_80492_1
crossref_primary_10_1007_s12602_025_10498_2
crossref_primary_10_3389_fmicb_2025_1522191
crossref_primary_10_3390_microorganisms12122653
crossref_primary_10_1016_j_jep_2024_119039
crossref_primary_10_3390_nu16234173
crossref_primary_10_1128_spectrum_01603_24
Cites_doi 10.2500/ajra.2016.30.4354
10.1111/lam.13716
10.1073/pnas.0904055107
10.1039/D2FO02567A
10.1378/chest.117.4.1162
10.3389/fimmu.2018.01546
10.3389/fnut.2022.821900
10.1097/WOX.0b013e3181f234d4
10.1159/000518952
10.1016/j.jaci.2003.09.015
10.1038/s41572-020-00227-0
10.1002/alr.23090
10.1002/cti2.1213
10.3390/nu12051427
10.1007/s00405-022-07485-6
10.4168/aair.2019.11.2.156
10.3390/nu13041315
10.1038/s41598-017-02260-8
10.1159/000515352
10.1111/imr.12619
10.1016/j.iac.2015.12.002
10.21873/anticanres.11405
10.1111/all.15454
10.1016/j.biopha.2019.109162
10.1002/eji.200425523
10.1111/all.14067
10.1002/alr.21492
10.3389/fimmu.2022.908010
10.3389/fnut.2021.789242
10.1016/j.jnutbio.2023.109370
10.1111/all.12383
10.1146/annurev-immunol-020711-075024
10.2147/JAA.S382978
10.1016/j.iac.2015.12.004
10.1159/000337764
10.1111/jam.13635
10.3390/ijms24010372
10.1016/S0140-6736(11)60130-X
10.2147/JAA.S395490
10.1016/j.jaci.2012.10.022
10.3390/cells12050768
10.1016/j.cyto.2008.03.004
10.1111/all.14756
10.7717/peerj.13444
10.1038/s41590-019-0479-x
10.3390/ijms21031009
10.3390/ijms21176266
10.1007/s10753-014-9944-8
ContentType Journal Article
Copyright Copyright © 2024 Han, Chen, Zhang, Zhang, He, Du and Li.
Copyright © 2024 Han, Chen, Zhang, Zhang, He, Du and Li. 2024 Han, Chen, Zhang, Zhang, He, Du and Li
Copyright_xml – notice: Copyright © 2024 Han, Chen, Zhang, Zhang, He, Du and Li.
– notice: Copyright © 2024 Han, Chen, Zhang, Zhang, He, Du and Li. 2024 Han, Chen, Zhang, Zhang, He, Du and Li
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.3389/fnut.2023.1291100
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Diet & Clinical Nutrition
EISSN 2296-861X
ExternalDocumentID oai_doaj_org_article_3f1e7b2360b94fe7b4adf5555c2da471
PMC10822906
38288067
10_3389_fnut_2023_1291100
Genre Journal Article
GroupedDBID 53G
5VS
9T4
AAFWJ
AAYXX
ACGFS
ACXDI
ADBBV
ADRAZ
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
GROUPED_DOAJ
HYE
KQ8
M48
M~E
OK1
PGMZT
RPM
IPNFZ
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c466t-ecbcf64b4dfd6fe0d4e931223fa11d29d1fb5a333b8ddc6771012524eb8e10a03
IEDL.DBID M48
ISSN 2296-861X
IngestDate Wed Aug 27 00:56:55 EDT 2025
Thu Aug 21 18:35:57 EDT 2025
Thu Sep 04 20:50:04 EDT 2025
Thu Apr 03 07:04:21 EDT 2025
Tue Jul 01 02:33:53 EDT 2025
Thu Apr 24 23:04:59 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords cytokine
GUANKE
probiotic
Lactobacillus plantarum
allergic rhinitis
Language English
License Copyright © 2024 Han, Chen, Zhang, Zhang, He, Du and Li.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c466t-ecbcf64b4dfd6fe0d4e931223fa11d29d1fb5a333b8ddc6771012524eb8e10a03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Mingsan Miao, Henan University of Chinese Medicine, China
Reviewed by: Naiara Dejani,University of São Paulo, Brazil
Peijun Tian, Jiangnan University, China
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fnut.2023.1291100
PMID 38288067
PQID 2920188669
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_3f1e7b2360b94fe7b4adf5555c2da471
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10822906
proquest_miscellaneous_2920188669
pubmed_primary_38288067
crossref_citationtrail_10_3389_fnut_2023_1291100
crossref_primary_10_3389_fnut_2023_1291100
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-01-15
PublicationDateYYYYMMDD 2024-01-15
PublicationDate_xml – month: 01
  year: 2024
  text: 2024-01-15
  day: 15
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in nutrition (Lausanne)
PublicationTitleAlternate Front Nutr
PublicationYear 2024
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Li (ref36) 2022; 279
Barrenas (ref38) 2008; 42
Kwon (ref43) 2010; 107
Cayrol (ref35) 2018; 281
Lin (ref29) 2017; 37
Zhang (ref3) 2019; 11
Xu (ref13) 2021; 8
Greiner (ref8) 2011; 378
Nur Husna (ref26) 2022; 10
Opal (ref27) 2000; 117
Gong (ref31) 2014; 37
Zhang (ref48) 2019; 117
Das (ref17) 2010; 3
Meltzer (ref2) 2016; 36
Liu (ref16) 2022; 15
Yang (ref22) 2022; 75
Bao (ref37) 2022; 15
Wang (ref46) 2023; 120
Ludwig (ref44) 2018; 9
Guvenc (ref9) 2016; 30
Bousquet (ref1) 2020; 6
Anania (ref18) 2021; 13
Fu (ref42) 2017; 7
Ghavami (ref45) 2020; 21
Zissler (ref39) 2021; 76
Powell (ref40) 2012; 30
Barata (ref28) 2019; 20
Bernstein (ref6) 2016; 36
Zajac (ref11) 2015; 5
Torre (ref20) 2022; 183
Oral (ref32) 2006; 36
Kang (ref19) 2020; 12
Meng (ref4) 2019; 74
Choi (ref21) 2018; 124
Huang (ref10) 2022; 9
Meltzer (ref15) 2013; 131
Jia (ref41) 2020; 9
Lin (ref30) 2020; 21
Pfaar (ref14) 2014; 69
Lin (ref23) 2023; 12
Zhang (ref7) 2022; 77
Wise (ref5) 2023; 13
Steiner (ref25) 2021; 182
Asaka (ref34) 2012; 158
Gu (ref47) 2023; 14
Du (ref12) 2022; 13
Borish (ref24) 2003; 112
Borgia (ref33) 2022; 24
References_xml – volume: 30
  start-page: 157
  year: 2016
  ident: ref9
  article-title: Do probiotics have a role in the treatment of allergic rhinitis? A comprehensive systematic review and meta-analysis
  publication-title: Am J Rhinol Allergy
  doi: 10.2500/ajra.2016.30.4354
– volume: 75
  start-page: 152
  year: 2022
  ident: ref22
  article-title: Oral administration of Lactiplantibacillus plantarum NR16 isolated from kimchi ameliorates murine allergic rhinitis
  publication-title: Lett Appl Microbiol
  doi: 10.1111/lam.13716
– volume: 107
  start-page: 2159
  year: 2010
  ident: ref43
  article-title: Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0904055107
– volume: 14
  start-page: 3982
  year: 2023
  ident: ref47
  article-title: Lactobacillus plantarum ZJ316 alleviates ulcerative colitis by inhibiting inflammation and regulating short-chain fatty acid levels and the gut microbiota in a mouse model
  publication-title: Food Funct
  doi: 10.1039/D2FO02567A
– volume: 117
  start-page: 1162
  year: 2000
  ident: ref27
  article-title: Anti-inflammatory cytokines
  publication-title: Chest
  doi: 10.1378/chest.117.4.1162
– volume: 9
  start-page: 1546
  year: 2018
  ident: ref44
  article-title: Lactobacillus rhamnosus GG-derived soluble mediators modulate adaptive immune cells
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2018.01546
– volume: 9
  start-page: 821900
  year: 2022
  ident: ref10
  article-title: Effect of probiotics on respiratory tract allergic disease and gut microbiota
  publication-title: Front Nutr
  doi: 10.3389/fnut.2022.821900
– volume: 3
  start-page: 239
  year: 2010
  ident: ref17
  article-title: Probiotics in treatment of allergic rhinitis
  publication-title: World Allergy Organ J
  doi: 10.1097/WOX.0b013e3181f234d4
– volume: 183
  start-page: 186
  year: 2022
  ident: ref20
  article-title: A pilot study on clinical scores, immune cell modulation, and microbiota composition in allergic patients with rhinitis and asthma treated with a probiotic preparation
  publication-title: Int Arch Allergy Immunol
  doi: 10.1159/000518952
– volume: 112
  start-page: 1021
  year: 2003
  ident: ref24
  article-title: Allergic rhinitis: systemic inflammation and implications for management
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2003.09.015
– volume: 6
  start-page: 95
  year: 2020
  ident: ref1
  article-title: Allergic rhinitis
  publication-title: Nat Rev Dis Primers
  doi: 10.1038/s41572-020-00227-0
– volume: 13
  start-page: 293
  year: 2023
  ident: ref5
  article-title: International consensus statement on allergy and rhinology: allergic rhinitis - 2023
  publication-title: Int Forum Allergy Rhinol
  doi: 10.1002/alr.23090
– volume: 9
  start-page: e1213
  year: 2020
  ident: ref41
  article-title: Porphyromonas gingivalis and Lactobacillus rhamnosus GG regulate the Th17/Treg balance in colitis via TLR4 and TLR2
  publication-title: Clin Transl Immunol
  doi: 10.1002/cti2.1213
– volume: 12
  start-page: 1427
  year: 2020
  ident: ref19
  article-title: Probiotic NVP-1703 alleviates allergic rhinitis by inducing IL-10 expression: a four-week clinical trial
  publication-title: Nutrients
  doi: 10.3390/nu12051427
– volume: 279
  start-page: 5089
  year: 2022
  ident: ref36
  article-title: Chemokines and chemokine receptors in allergic rhinitis: from mediators to potential therapeutic targets
  publication-title: Eur Arch Otorhinolaryngol
  doi: 10.1007/s00405-022-07485-6
– volume: 11
  start-page: 156
  year: 2019
  ident: ref3
  article-title: Increasing prevalence of allergic rhinitis in China
  publication-title: Allergy Asthma Immunol Res
  doi: 10.4168/aair.2019.11.2.156
– volume: 13
  start-page: 1315
  year: 2021
  ident: ref18
  article-title: Treatment with a probiotic mixture containing Bifidobacterium animalis Subsp. Lactis BB12 and Enterococcus faecium L3 for the prevention of allergic rhinitis symptoms in children: a randomized controlled trial
  publication-title: Nutrients
  doi: 10.3390/nu13041315
– volume: 7
  start-page: 1987
  year: 2017
  ident: ref42
  article-title: Lactic acid bacteria-specific induction of CD4(+)Foxp3(+)T cells ameliorates shrimp tropomyosin-induced allergic response in mice via suppression of mTOR signaling
  publication-title: Sci Rep
  doi: 10.1038/s41598-017-02260-8
– volume: 182
  start-page: 807
  year: 2021
  ident: ref25
  article-title: Probiotic potential of Lactobacillus species in allergic rhinitis
  publication-title: Int Arch Allergy Immunol
  doi: 10.1159/000515352
– volume: 281
  start-page: 154
  year: 2018
  ident: ref35
  article-title: Interleukin-33 (IL-33): a nuclear cytokine from the IL-1 family
  publication-title: Immunol Rev
  doi: 10.1111/imr.12619
– volume: 36
  start-page: 235
  year: 2016
  ident: ref2
  article-title: Allergic rhinitis: burden of illness, quality of life, comorbidities, and control
  publication-title: Immunol Allergy Clin N Am
  doi: 10.1016/j.iac.2015.12.002
– volume: 37
  start-page: 963
  year: 2017
  ident: ref29
  article-title: The role of IL-7 in immunity and cancer
  publication-title: Anticancer Res
  doi: 10.21873/anticanres.11405
– volume: 77
  start-page: 3309
  year: 2022
  ident: ref7
  article-title: Update on pathomechanisms and treatments in allergic rhinitis
  publication-title: Allergy
  doi: 10.1111/all.15454
– volume: 117
  start-page: 109162
  year: 2019
  ident: ref48
  article-title: Flos Abelmoschus manihot extract attenuates DSS-induced colitis by regulating gut microbiota and Th17/Treg balance
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2019.109162
– volume: 36
  start-page: 380
  year: 2006
  ident: ref32
  article-title: Regulation of T cells and cytokines by the interleukin-10 (IL-10)-family cytokines IL-19, IL-20, IL-22, IL-24 and IL-26
  publication-title: Eur J Immunol
  doi: 10.1002/eji.200425523
– volume: 74
  start-page: 2320
  year: 2019
  ident: ref4
  article-title: Recent developments and highlights in allergic rhinitis
  publication-title: Allergy
  doi: 10.1111/all.14067
– volume: 5
  start-page: 524
  year: 2015
  ident: ref11
  article-title: A systematic review and meta-analysis of probiotics for the treatment of allergic rhinitis
  publication-title: Int Forum Allergy Rhinol
  doi: 10.1002/alr.21492
– volume: 13
  start-page: 908010
  year: 2022
  ident: ref12
  article-title: The beneficial role of probiotic Lactobacillus in respiratory diseases
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2022.908010
– volume: 8
  start-page: 789242
  year: 2021
  ident: ref13
  article-title: Boosting vaccine-elicited respiratory mucosal and systemic COVID-19 immunity in mice with the oral Lactobacillus plantarum
  publication-title: Front Nutr
  doi: 10.3389/fnut.2021.789242
– volume: 120
  start-page: 109370
  year: 2023
  ident: ref46
  article-title: Gut-derived short-chain fatty acids bridge cardiac and systemic metabolism and immunity in heart failure
  publication-title: J Nutr Biochem
  doi: 10.1016/j.jnutbio.2023.109370
– volume: 69
  start-page: 854
  year: 2014
  ident: ref14
  article-title: Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI position paper
  publication-title: Allergy
  doi: 10.1111/all.12383
– volume: 30
  start-page: 39
  year: 2012
  ident: ref40
  article-title: Regulation of immune responses by mTOR
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev-immunol-020711-075024
– volume: 15
  start-page: 1413
  year: 2022
  ident: ref16
  article-title: Research advances in the treatment of allergic rhinitis by probiotics
  publication-title: J Asthma Allergy
  doi: 10.2147/JAA.S382978
– volume: 36
  start-page: 261
  year: 2016
  ident: ref6
  article-title: Allergic rhinitis: mechanisms and treatment
  publication-title: Immunol Allergy Clin N Am
  doi: 10.1016/j.iac.2015.12.004
– volume: 158
  start-page: 47
  year: 2012
  ident: ref34
  article-title: Elevated levels of interleukin-33 in the nasal secretions of patients with allergic rhinitis
  publication-title: Int Arch Allergy Immunol
  doi: 10.1159/000337764
– volume: 124
  start-page: 821
  year: 2018
  ident: ref21
  article-title: Oral administration of Lactobacillus plantarum CJLP133 and CJLP243 alleviates birch pollen-induced allergic rhinitis in mice
  publication-title: J Appl Microbiol
  doi: 10.1111/jam.13635
– volume: 24
  start-page: 372
  year: 2022
  ident: ref33
  article-title: IL-33 and IL-37: a possible Axis in skin and allergic diseases
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms24010372
– volume: 378
  start-page: 2112
  year: 2011
  ident: ref8
  article-title: Allergic rhinitis
  publication-title: Lancet
  doi: 10.1016/S0140-6736(11)60130-X
– volume: 15
  start-page: 1805
  year: 2022
  ident: ref37
  article-title: Role of chemokines and inflammatory cells in respiratory allergy
  publication-title: J Asthma Allergy
  doi: 10.2147/JAA.S395490
– volume: 131
  start-page: 379
  year: 2013
  ident: ref15
  article-title: Reliability, validity, and responsiveness of the rhinitis control assessment test in patients with rhinitis
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2012.10.022
– volume: 12
  start-page: 768
  year: 2023
  ident: ref23
  article-title: Lacticaseibacillus paracasei GM-080 ameliorates allergic airway inflammation in children with allergic rhinitis: from an animal model to a double-blind, randomized, placebo-controlled trial
  publication-title: Cells
  doi: 10.3390/cells12050768
– volume: 42
  start-page: 325
  year: 2008
  ident: ref38
  article-title: Gender differences in inflammatory proteins and pathways in seasonal allergic rhinitis
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2008.03.004
– volume: 76
  start-page: 2461
  year: 2021
  ident: ref39
  article-title: Allergen-specific immunotherapy induces the suppressive secretoglobin 1A1 in cells of the lower airways
  publication-title: Allergy
  doi: 10.1111/all.14756
– volume: 10
  start-page: e13444
  year: 2022
  ident: ref26
  article-title: IL-4/IL-13 axis as therapeutic targets in allergic rhinitis and asthma
  publication-title: PeerJ
  doi: 10.7717/peerj.13444
– volume: 20
  start-page: 1584
  year: 2019
  ident: ref28
  article-title: Flip the coin: IL-7 and IL-7R in health and disease
  publication-title: Nat Immunol
  doi: 10.1038/s41590-019-0479-x
– volume: 21
  start-page: 1009
  year: 2020
  ident: ref30
  article-title: IL-20 in acute kidney injury: role in pathogenesis and potential as a therapeutic target
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms21031009
– volume: 21
  start-page: 6266
  year: 2020
  ident: ref45
  article-title: Immunomodulation and generation of Tolerogenic dendritic cells by probiotic Bacteria in patients with inflammatory bowel disease
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms21176266
– volume: 37
  start-page: 2099
  year: 2014
  ident: ref31
  article-title: Interleukin-20 promotes airway remodeling in asthma
  publication-title: Inflammation
  doi: 10.1007/s10753-014-9944-8
SSID ssj0001325414
Score 2.3027196
Snippet Currently, the prevalence of allergic rhinitis (AR) remains high and there is a great need to develop better and safer ways to alleviate AR symptoms. The...
BackgroundCurrently, the prevalence of allergic rhinitis (AR) remains high and there is a great need to develop better and safer ways to alleviate AR symptoms....
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1291100
SubjectTerms allergic rhinitis
cytokine
GUANKE
Lactobacillus plantarum
Nutrition
probiotic
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQnrgg3gRYZCTEASlsHDtOclxglxWPigOV9mbZsc1G5FG16Ur9I_t7mXHSqkUILuTkJI5szUw8M_Hk-wh5VTHmbSlszLgtYvD4OgYnyGPpA1648zLgFnydyYu5-HSZXe5RfWFN2AgPPAruhHvmcpNymZhSeGgKbX0GR5VaLcLf42lSJnvJVPi6wlPktx63MSELK098t8bSyZS_BQ-HOGkHjijg9f8pyPy9VnLP-ZzfJXemqJGejrO9R2657j6JPtRuoK_pBO3Z0NkWWf8BufkW8JWgO_2CjDpGV3XTrFd00YAo9XLd0o_z09nnMzoWdMCa12wo8qpc1xh9huYSVkW6vKqxvmhFV5t2MfTtipoNbXsbaL-6HxQdY7Bd2nt6DZl3D6NUm6H_iQX1VHeWgl204-lDMj8_-_7-Ip4oGOJKSDnErjKVl8II6630LrHClZxBSOE1YzYtLfMm05xzU1hbyTxHuLAsFc4UjiU64Y_IUdd37gmhCCWWeVhfZVIIrdPSyLQwOfe5g5DF84gkW32oasInR5qMRkGegipUqEKFKlSTCiPyZvfIYgTn-Fvnd6jkXUfE1Q4XwNrUZG3qX9YWkZdbE1HwHuLmiu4cCFYh6xcrCinLiDweTWY3FIe0toCwICLFgTEdzOXwTldfBaxvNiHyP_0fs39GboNEsOooZtlzcjQs1-4YYqrBvAivzy8_3SP8
  priority: 102
  providerName: Directory of Open Access Journals
Title Probiotic Lactobacillus plantarum GUANKE effectively alleviates allergic rhinitis symptoms by modulating functions of various cytokines and chemokines
URI https://www.ncbi.nlm.nih.gov/pubmed/38288067
https://www.proquest.com/docview/2920188669
https://pubmed.ncbi.nlm.nih.gov/PMC10822906
https://doaj.org/article/3f1e7b2360b94fe7b4adf5555c2da471
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZKuXBBvAmFykiIA1JKHCdOckCoQEsFdMWBlfYW2bHdRs0m22y2In-E38uMk12xaIVETnk4L8_Y30wy-j5CXhWMWZ1F2mdcpz4gvvQBBLkvrOMLN1Y43oLziTibRl9m8WyPrOWtxg5c7kztUE9q2lZHP6_79zDg32HGCXj71tYrrIoM-RGAF1Kg3SK3AZgE5mLnY7TvPrnwEEWvUW4uzISfCjYb_nPuvsoWUjlC_11R6N_FlH-g0-k9cncMK-nx4Af3yZ6pHxDvU2k6-pqO3J8Vnayp9x-SX98dARM0p99QckfJoqyq1ZIuKuhr2a7m9PP0ePL1hA4VHzApVj1F4ZWbEsNTt9rCtEnbyxILkJZ02c8XXTNfUtXTeaOdLlh9QRE5nXPTxtIbSM0buEvRd80VVtxTWWsKjjMfNh-R6enJj49n_qjR4BeREJ1vClVYEalIWy2sCXRkMs4g5rCSMR1mmlkVS865SrUuRJIgn1gcRkalhgUy4I_Jft3U5imhyDUWW5iARZBGUoaZEmGqEm4TAzGN5R4J1vbIi5HAHHU0qhwSGTRhjibM0YT5aEKPvNmcshjYO_7V-AMaedMQibfdjqa9yMdxnHPLTKJCLgKVRRZWI6ltDEsRaglA75GXaxfJYaDi3xdZG-jYHGXBWJoKkXnkyeAym1txyHtTiBs8km4509azbB-py0tHBs5Gyv5n__OqB-QObGL5kc_i52S_a1fmBQRXnTp0HyUO3cD5DdGbJcY
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Probiotic+Lactobacillus+plantarum+GUANKE+effectively+alleviates+allergic+rhinitis+symptoms+by+modulating+functions+of+various+cytokines+and+chemokines&rft.jtitle=Frontiers+in+nutrition+%28Lausanne%29&rft.au=Han%2C+Haijun&rft.au=Chen%2C+Guoliang&rft.au=Zhang%2C+Bin&rft.au=Zhang%2C+Xuewen&rft.date=2024-01-15&rft.issn=2296-861X&rft.eissn=2296-861X&rft.volume=10&rft_id=info:doi/10.3389%2Ffnut.2023.1291100&rft.externalDBID=n%2Fa&rft.externalDocID=10_3389_fnut_2023_1291100
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2296-861X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2296-861X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2296-861X&client=summon